Karachi-based Getz Pharma is willing to invest up to $100 million to set up a vaccine manufacturing facility in Pakistan, reported an international media outlet on Thursday, as governments and organisations around the world push for increased production of Covid-19 vaccines in developing countries. According to the report, Getz Pharma CEO Khalid Mahmood expressed willingness to invest millions of dollars to set up the plant that would be capable of making mRNA vaccines to overcome the vaccine shortage. mRNA vaccines are a new type of vaccine to protect against infectious diseases, according to the Centers for Disease Control and Prevention. The benefit of mRNA vaccines, like all vaccines, is that those vaccinated gain protection without ever having to risk the serious consequences of getting sick with COVID-19. Presently, the top Covid-19 vaccines such as those from Pfizer and Moderna use mRNA technology, whereas Chinese Sinopharm and Sinovac vaccines are whole virus vaccines.
Source: Pakistan Today May 07, 2021 17:37 UTC